Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype

Author:

Maus MateORCID,López-Polo VanessaORCID,Mateo LidiaORCID,Lafarga Miguel,Aguilera MònicaORCID,De Lama Eugenia,Meyer Kathleen,Sola AnnaORCID,Lopez-Martinez CeciliaORCID,López-Alonso Ines,Guasch-Piqueras MarcORCID,Hernandez-Gonzalez FernandaORCID,Chaib SelimORCID,Rovira MiguelORCID,Sanchez MaykaORCID,Faner Rosa,Agusti AlvarORCID,Diéguez-Hurtado Rodrigo,Ortega Sagrario,Manonelles AnnaORCID,Engelhardt StefanORCID,Monteiro FreddyORCID,Stephan-Otto Attolini CamilleORCID,Prats Neus,Albaiceta GuillermoORCID,Cruzado Josep M.ORCID,Serrano ManuelORCID

Abstract

AbstractFibrogenesis is part of a normal protective response to tissue injury that can become irreversible and progressive, leading to fatal diseases. Senescent cells are a main driver of fibrotic diseases through their secretome, known as senescence-associated secretory phenotype (SASP). Here, we report that cellular senescence, and multiple types of fibrotic diseases in mice and humans are characterized by the accumulation of iron. We show that vascular and hemolytic injuries are efficient in triggering iron accumulation, which in turn can cause senescence and promote fibrosis. Notably, we find that senescent cells persistently accumulate iron, even when the surge of extracellular iron has subdued. Indeed, under normal conditions of extracellular iron, cells exposed to different types of senescence-inducing insults accumulate abundant ferritin-bound iron, mostly within lysosomes, and present high levels of labile iron, which fuels the generation of reactive oxygen species and the SASP. Finally, we demonstrate that detection of iron by magnetic resonance imaging might allow non-invasive assessment of fibrotic burden in the kidneys of mice and in patients with renal fibrosis. Our findings suggest that iron accumulation plays a central role in senescence and fibrosis, even when the initiating events may be independent of iron, and identify iron metabolism as a potential therapeutic target for senescence-associated diseases.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Physiology (medical),Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3